• Citer

Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial

par Sonnenblick, Amir;Kroep, Judith;Cufer, Tanja;Simon, Sergio;Salman, Pamela;Toi, Masakazu;Harris, Lyndsay;Gralow, Julie;Keane, Maccon;Moreno-Aspitia, Alvaro;Piccart-Gebhart, Martine ;Agbor‑Tarh, Dominique;de Azambuja, Evandro ;Bradbury, Ian;Di Cosimo, Serena;Abdel Azim, Hatem Hamdy ;Fumagalli, Debora ;Sarp, Severine;Wolff, Andrew A C A.A.;Andersson, Michael
Référence Journal of clinical oncology, 35, 13, page (1421-1429)
Publication Publié, 2017-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial
Auteur:	Sonnenblick, Amir; Kroep, Judith; Cufer, Tanja; Simon, Sergio; Salman, Pamela; Toi, Masakazu; Harris, Lyndsay; Gralow, Julie; Keane, Maccon; Moreno-Aspitia, Alvaro; Piccart-Gebhart, Martine; Agbor‑Tarh, Dominique; de Azambuja, Evandro; Bradbury, Ian; Di Cosimo, Serena; Abdel Azim, Hatem Hamdy; Fumagalli, Debora; Sarp, Severine; Wolff, Andrew A C A.A.; Andersson, Michael
Informations sur la publication:	Journal of clinical oncology, 35, 13, page (1421-1429)
Statut de publication:	Publié, 2017-05
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2016.69.7722
	info:scp/85016977704